Globally, the hematology market is assessed as a mature market and is characterized by intense competition with a high demand for clinical coagulation tests. With the increase in the number of cardiovascular surgical procedures being performed, there has been a considerable need for coagulation testing. Today, an increasing number of patients are using anticoagulants after having a mechanical heart valve implantation performed, as well as to prevent coagulation accidents like pulmonary embolisms, deep venous thrombosis, strokes, and myocardial infarctions. With increasing pressure on clinicians to normalize anticoagulation therapy, continuous monitoring of coagulation factors has become a primary protocol, thus driving the market for coagulation.
The Americas commanded the largest share (42%) of the global coagulation market at an estimated $1,240.8 million in 2013, expected to reach $1,638.7 million by 2018, at a CAGR of 6.0% from 2013 to 2018. Europe holds the second position in this market. Germany commanded the largest share (20%) of the European coagulation market at an estimated $186.9 million in 2013 and is expected to reach $231.1 million by 2018, at a CAGR of 4.5% from 2013 to 2018. The Asian coagulation market is growing in double digits and will continue to grow in the coming years. China commanded the largest share (53%) of the Asian market, at an estimated $148.0 million in 2013, and is expected to reach $283.6 million by 2018, at a CAGR of 14.6% from 2013 to 2018.
The Centers for Medicare & Medicaid Services (CMS) has estimated that healthcare spending in the U.S. is expected to grow from $2.7 trillion in 2011 to about $4.6 trillion in 2018, at a CAGR of 6.8% for the same period. Similarly, in emerging countries, awareness and an increasing middle-class population, with a more disposable income to spend on healthcare, will be a driving force for the growth of this market.
The report on the global coagulation market analyzes the market by two segments: coagulation instruments and coagulation reagents. The report also provides an extensive competitive landscape of companies operating in this market. Some of the key players in coagulation market include Abbott Laboratories, American Diagnostica, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Chrono-Log Corporation, Helena Laboratories, Hyphen BioMed, Nanogen, Inc., Roche Holding Ltd., Sysmex Corporation, Thermo Fischer Scientific, Inc. and ZyCare, Inc., and others.
The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report.
Report Customization Options
Along with market data, you can also customize MMM offerings that are in keeping with your company’s specific needs. Customize your report on the global coagulation market for to get an insight into all-inclusive industry standards and a deep-dive analysis of the following considerations:
- Unmet needs, revenue pockets, and potential areas for expansion in the coagulation market
Market Analysis & Data Forecast
- Indications, demographics, and therapeutic market segments
Current and Emerging Products
- Analysis of current and emerging coagulation and immunodiagnostic tests
- Review of current instrumentation technologies in coagulation market
- Pricing trend of new high-value coagulation tests
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix which gives a detailed comparison of the product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connection tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Alternative Products: Impact Analysis
MMM’s Healthcare Decision Making Quadrant: It is an innovative and useful quadrant for vendors who wish to analyze potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate, and healthcare expenditure).
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Products
4.3 Services & Software
5 By Technologies
5.3 Chemical (Chromogenic) Assays
5.4 Molecular PCR Testing
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Mechanical and Immunologic, Chemical (Chromogenic) Assays...
Immunologic and Mechanical, Chemical (Chromogenic) Assays...
Chemical (Chromogenic) Assays
Chemical (Chromogenic) Assays and Mechanical, Immunologic and
Molecular PCR Testing
Molecular PCR Testing and Mechanical, Immunologic and
TEG/Thrombelastrography and ROTEM/Rotational Thromboelastrometry and
ROTEM/Rotational Thromboelastrometry and TEG/Thrombelastrography and
Sonoclot and TEG/Thrombelastrography and
Europe holds the second position in the global coagulation market after the Americas. Germany commanded the largest share (20%) at an estimated $186.9 million in 2013 and is expected to reach $231.1 million by 2018, at a CAGR of 4.5% from 2013 to 2018. The market can be segmented by geographies, end users, companies, and macro indicators. A deep-dive analysis of the top players of this market has been provided in this report.
North America Coagulation
The Americas commanded the largest share 42% of the Global Coagulation market at an estimated $1240.8 million in 2013 and are expected to reach $1638.7 million by 2018, at a CAGR of 6% from 2013 to 2018. The report “North American Coagulation Market forecast for 2018 “analyzes the market by two segments such as coagulation instruments and coagulation reagents.
Asian Coagulation market is growing in double digit and will continue to grow in future. China commanded the largest share 53% at an estimated $148.0 million in 2013 and is expected to reach $283.6 million by 2018, at a CAGR of 14.6% from 2013 to 2018. The report “Asian Coagulation Market forecast for 2018 “analyzes the market by two segments such as coagulation instruments and coagulation reagents.